TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

J Gregory Cairncross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.